Hypertension guidelines and goals of treatment: role of calcium antagonists.
Hansson
L
L
University of Uppsala, Department of Public Health, PO Box 609, S- 751 25 Uppsala, Sweden.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000367:Age Factors; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D012737:Sex Factors; D014944:World Health Organization
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D004232:Diuretics